Stock Research for ACUR

ACUR

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ACUR Stock Chart & Research Data

The ACUR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACUR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ACUR Due diligence Resources & Stock Charts

The ACUR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ACUR Detailed Price Forecast - CNN Money CNN View ACUR Detailed Summary - Google Finance
Yahoo View ACUR Detailed Summary - Yahoo! Finance Zacks View ACUR Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ACUR Trends & Analysis - Trade-Ideas Barrons View ACUR Major Holders - Barrons
NASDAQ View ACUR Call Transcripts - NASDAQ Seeking View ACUR Breaking News & Analysis - Seeking Alpha
Spotlight View ACUR Annual Report - CompanySpotlight.com OTC Report View ACUR OTC Short Report - OTCShortReport.com
TradeKing View ACUR Fundamentals - TradeKing Charts View ACUR SEC Filings - Bar Chart
WSJ View Historical Prices for ACUR - The WSJ Morningstar View Performance/Total Return for ACUR - Morningstar
MarketWatch View the Analyst Estimates for ACUR - MarketWatch CNBC View the Earnings History for ACUR - CNBC
StockMarketWatch View the ACUR Earnings - StockMarketWatch MacroAxis View ACUR Buy or Sell Recommendations - MacroAxis
Bullish View the ACUR Bullish Patterns - American Bulls Short Pains View ACUR Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ACUR Stock Mentions - StockTwits PennyStocks View ACUR Stock Mentions - PennyStockTweets
Twitter View ACUR Stock Mentions - Twitter Invest Hub View ACUR Investment Forum News - Investor Hub
Yahoo View ACUR Stock Mentions - Yahoo! Message Board Seeking Alpha View ACUR Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ACUR - SECform4.com Insider Cow View Insider Transactions for ACUR - Insider Cow
CNBC View ACUR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ACUR - OTC Markets
Yahoo View Insider Transactions for ACUR - Yahoo! Finance NASDAQ View Institutional Holdings for ACUR - NASDAQ


Stock Charts

FinViz View ACUR Stock Insight & Charts - FinViz.com StockCharts View ACUR Investment Charts - StockCharts.com
BarChart View ACUR Stock Overview & Charts - BarChart Trading View View ACUR User Generated Charts - Trading View




Latest Financial News for ACUR


Acura Pharmaceuticals, Inc. Restructures Debt Obligations
Posted on Tuesday October 09, 2018

Acura Pharmaceuticals, Inc. (ACUR), a specialty pharmaceutical company focused on innovating abuse deterrent drugs, today announced that on October 5, 2018 we restructured our debt obligations by (a) receiving an additional $1.8 million loan from John Schutte and (b) retiring in full our senior secured debt with Oxford Finance for a payment of $1.5 million.  Mr. Schutte’s loans to the Company total $4.0 million. Pursuant to the terms of Mr. Schutte’s debt, after the retirement of the Oxford Finance debt, the Company is required to grant him a security interest in its assets.  The balance of Mr. Schutte’s loan will extend our operations into November 2018 while the Company remains focused on licensing its lead asset LTX-03. In the absence of closing a licensing agreement upon acceptable terms or securing additional funding, Acura will be required to scale back or terminate operations and/or seek protection under applicable bankruptcy laws.


Acura Pharmaceuticals Announces Second Quarter 2018 Financial Results
Posted on Tuesday August 14, 2018

PALATINE, Ill., Aug. 14, 2018-- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and six months ended June ...



Posted on Wednesday December 31, 1969



Posted on Wednesday December 31, 1969


Stock Market & Investing Books

Enter a stock symbol to view the stock details.